BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 32710091)

  • 1. Research funding after COVID-19.
    Prudêncio M; Costa JC
    Nat Microbiol; 2020 Aug; 5(8):986. PubMed ID: 32710091
    [No Abstract]   [Full Text] [Related]  

  • 2. How do we Find a "New Normal" for Industry and Business After COVID-19 Shut Downs?
    J Occup Environ Med; 2020 Sep; 62(9):e531-e534. PubMed ID: 32890225
    [No Abstract]   [Full Text] [Related]  

  • 3. Opinion: Here's how we restore productivity and vigor to the biomedical research workforce in the midst of COVID-19.
    Omary MB; Hassan M
    Proc Natl Acad Sci U S A; 2020 Aug; 117(33):19612-19614. PubMed ID: 32727896
    [No Abstract]   [Full Text] [Related]  

  • 4. Promoting health equity in the era of COVID-19.
    Farley JH; Hines J; Lee NK; Brooks SE; Nair N; Brown CL; Doll KM; Sullivan EJ; Chapman-Davis E
    Gynecol Oncol; 2020 Jul; 158(1):25-31. PubMed ID: 32446719
    [No Abstract]   [Full Text] [Related]  

  • 5. Tackling population health challenges as we build back from the pandemic.
    McCartney G; Douglas M; Taulbut M; Katikireddi SV; McKee M
    BMJ; 2021 Dec; 375():e066232. PubMed ID: 34876411
    [No Abstract]   [Full Text] [Related]  

  • 6. Infectious diseases in Yemen.
    Burki T
    Lancet Infect Dis; 2021 May; 21(5):610-611. PubMed ID: 33894845
    [No Abstract]   [Full Text] [Related]  

  • 7. Pricing infectious disease. The economic and health implications of infectious diseases.
    Fonkwo PN
    EMBO Rep; 2008 Jul; 9 Suppl 1(Suppl 1):S13-7. PubMed ID: 18578017
    [No Abstract]   [Full Text] [Related]  

  • 8. Gaza-ceasefire and prepare for a surge in infectious diseases!
    Nsutebu E; AlDhaheri F; Albasata H; Aldhanhani H; Hussein S; Al Hammadi A
    Postgrad Med J; 2024 Jun; 100(1185):443-444. PubMed ID: 38376178
    [No Abstract]   [Full Text] [Related]  

  • 9. Plagues and peoples revisited. Basic and strategic research for ingectious disease control at the intergace in the life, health and social sciences.
    Sommerfeld J
    EMBO Rep; 2003 Jun; 4 Spec No(Suppl 1):S32-4. PubMed ID: 12789403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for reducing chronic disease burden during pandemics.
    Al Meslamani AZ
    Curr Med Res Opin; 2024 Feb; 40(2):193-197. PubMed ID: 38095584
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential Gene Expression of Malaria Parasite in Response to Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG).
    Balau A; Sobral D; Abrantes P; Santos I; Mixão V; Gomes JP; Antunes S; Arez AP
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of COVID-19 on open access publishing in radiology and nuclear medicine: an in-depth analysis.
    Malkawi L; Hassan R; Alshrouf MA; Al-Ryalat N; AlRyalat SA
    J Med Life; 2023 Jul; 16(7):967-973. PubMed ID: 37900061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collateral damage: has the COVID-19 pandemic more strongly impacted medical research than other scientific areas?
    Farji-Brener A; Amador-Vargas S
    PeerJ; 2023; 11():e15436. PubMed ID: 37334115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scientific priorities and relational dynamics during the COVID-19 pandemic: A qualitative study.
    Smith EM; Rakestraw C; Farroni JS
    Account Res; 2024 May; 31(4):356-376. PubMed ID: 36168913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adapting teaching and learning in times of COVID-19: a comparative assessment among higher education institutions in a global health network in 2020.
    Puradiredja DI; Kintu-Sempa L; Eyber C; Weigel R; Broucker B; Lindkvist M; Casamitjana N; Reynolds R; Klinkel HF; Matteelli A; Froeschl G
    BMC Med Educ; 2022 Jun; 22(1):507. PubMed ID: 35764985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterising COVID-19 empirical research production in Latin America and the Caribbean: A scoping review.
    Mansilla C; Herrera CA; Boeira L; Yearwood A; Lopez AS; Colunga-Lozano LE; Brocard E; Villacres T; Vélez M; Di Paolantonio G; Reveiz L
    PLoS One; 2022; 17(2):e0263981. PubMed ID: 35171957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research integrity during the COVID-19 pandemic: Perspectives of health science researchers at an Academic Health Science Center.
    Smith EMR; Rakestraw C; Farroni JS
    Account Res; 2023 Dec; 30(7):471-492. PubMed ID: 35038939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the COVID-19 pandemic on publication dynamics and non-COVID-19 research production.
    Raynaud M; Goutaudier V; Louis K; Al-Awadhi S; Dubourg Q; Truchot A; Brousse R; Saleh N; Giarraputo A; Debiais C; Demir Z; Certain A; Tacafred F; Cortes-Garcia E; Yanes S; Dagobert J; Naser S; Robin B; Bailly É; Jouven X; Reese PP; Loupy A
    BMC Med Res Methodol; 2021 Nov; 21(1):255. PubMed ID: 34809561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The unintended consequences of the pandemic on non-pandemic research activities.
    Walker J; Brewster C; Fontinha R; Haak-Saheem W; Benigni S; Lamperti F; Ribaudo D
    Res Policy; 2022 Jan; 51(1):104369. PubMed ID: 34565926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community and topic modeling for infectious disease clinical trial recommendation.
    Elkin ME; Zhu X
    Netw Model Anal Health Inform Bioinform; 2021; 10(1):47. PubMed ID: 34254037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.